131 related articles for article (PubMed ID: 21364414)
1. Optimization of human tendon tissue engineering: peracetic acid oxidation for enhanced reseeding of acellularized intrasynovial tendon.
Woon CYL; Pridgen BC; Kraus A; Bari S; Pham H; Chang J
Plast Reconstr Surg; 2011 Mar; 127(3):1107-1117. PubMed ID: 21364414
[TBL] [Abstract][Full Text] [Related]
2. Flexor tendon tissue engineering: acellularized and reseeded tendon constructs.
Chong AKS; Riboh J; Smith RL; Lindsey DP; Pham HM; Chang J
Plast Reconstr Surg; 2009 Jun; 123(6):1759-1766. PubMed ID: 19483576
[TBL] [Abstract][Full Text] [Related]
3. Tissue-engineered intrasynovial tendons: optimization of acellularization and seeding.
Zhang AY; Bates SJ; Morrow E; Pham H; Pham B; Chang J
J Rehabil Res Dev; 2009; 46(4):489-98. PubMed ID: 19882484
[TBL] [Abstract][Full Text] [Related]
4. Optimization of human tendon tissue engineering: synergistic effects of growth factors for use in tendon scaffold repopulation.
Raghavan SS; Woon CYL; Kraus A; Megerle K; Pham H; Chang J
Plast Reconstr Surg; 2012 Feb; 129(2):479-489. PubMed ID: 22286428
[TBL] [Abstract][Full Text] [Related]
5. A comparison of tenocytes and mesenchymal stem cells for use in flexor tendon tissue engineering.
Kryger GS; Chong AK; Costa M; Pham H; Bates SJ; Chang J
J Hand Surg Am; 2007; 32(5):597-605. PubMed ID: 17481995
[TBL] [Abstract][Full Text] [Related]
6. Human flexor tendon tissue engineering: revitalization of biostatic allograft scaffolds.
Woon CY; Farnebo S; Schmitt T; Kraus A; Megerle K; Pham H; Yan X; Gambhir SS; Chang J
Tissue Eng Part A; 2012 Dec; 18(23-24):2406-17. PubMed ID: 22712522
[TBL] [Abstract][Full Text] [Related]
7. Human flexor tendon tissue engineering: in vivo effects of stem cell reseeding.
Schmitt T; Fox PM; Woon CY; Farnebo SJ; Bronstein JA; Behn A; Pham H; Chang J
Plast Reconstr Surg; 2013 Oct; 132(4):567e-576e. PubMed ID: 24076704
[TBL] [Abstract][Full Text] [Related]
8. Flexor tendon tissue engineering: acellularization of human flexor tendons with preservation of biomechanical properties and biocompatibility.
Pridgen BC; Woon CY; Kim M; Thorfinn J; Lindsey D; Pham H; Chang J
Tissue Eng Part C Methods; 2011 Aug; 17(8):819-28. PubMed ID: 21548795
[TBL] [Abstract][Full Text] [Related]
9. A new strategy for the decellularisation of large equine tendons as biocompatible tendon substitutes.
Bottagisio M; Pellegata AF; Boschetti F; Ferroni M; Moretti M; Lovati AB
Eur Cell Mater; 2016 Jul; 32():58-73. PubMed ID: 27386840
[TBL] [Abstract][Full Text] [Related]
10. Flexor tendon tissue engineering: temporal distribution of donor tenocytes versus recipient cells.
Thorfinn J; Saber S; Angelidis IK; Ki SH; Zhang AY; Chong AK; Pham HM; Lee GK; Chang J
Plast Reconstr Surg; 2009 Dec; 124(6):2019-2026. PubMed ID: 19952658
[TBL] [Abstract][Full Text] [Related]
11. The Development of a Xenograft-Derived Scaffold for Tendon and Ligament Reconstruction Using a Decellularization and Oxidation Protocol.
Seyler TM; Bracey DN; Plate JF; Lively MO; Mannava S; Smith TL; Saul JM; Poehling GG; Van Dyke ME; Whitlock PW
Arthroscopy; 2017 Feb; 33(2):374-386. PubMed ID: 27692557
[TBL] [Abstract][Full Text] [Related]
12. Intratendinous Injection of Hydrogel for Reseeding Decellularized Human Flexor Tendons.
Long C; Galvez MG; Legrand A; Joubert LM; Wang Z; Chattopadhyay A; Chang J; Fox PM
Plast Reconstr Surg; 2017 Jun; 139(6):1305e-1314e. PubMed ID: 28538572
[TBL] [Abstract][Full Text] [Related]
13. Tissue engineering of the anterior cruciate ligament: a new method using acellularized tendon allografts and autologous fibroblasts.
Tischer T; Vogt S; Aryee S; Steinhauser E; Adamczyk C; Milz S; Martinek V; Imhoff AB
Arch Orthop Trauma Surg; 2007 Nov; 127(9):735-41. PubMed ID: 17541614
[TBL] [Abstract][Full Text] [Related]
14. Human flexor tendon tissue engineering: decellularization of human flexor tendons reduces immunogenicity in vivo.
Raghavan SS; Woon CY; Kraus A; Megerle K; Choi MS; Pridgen BC; Pham H; Chang J
Tissue Eng Part A; 2012 Apr; 18(7-8):796-805. PubMed ID: 22011137
[TBL] [Abstract][Full Text] [Related]
15. Discussion. Flexor tendon tissue engineering: acellularized and reseeded tendon constructs.
Haase SC; Chung KC
Plast Reconstr Surg; 2009 Jun; 123(6):1767-1768. PubMed ID: 19483577
[No Abstract] [Full Text] [Related]
16. Flexor tendon tissue engineering: bioreactor cyclic strain increases construct strength.
Saber S; Zhang AY; Ki SH; Lindsey DP; Smith RL; Riboh J; Pham H; Chang J
Tissue Eng Part A; 2010 Jun; 16(6):2085-90. PubMed ID: 20109062
[TBL] [Abstract][Full Text] [Related]
17. Repair of tendon defect with dermal fibroblast engineered tendon in a porcine model.
Liu W; Chen B; Deng D; Xu F; Cui L; Cao Y
Tissue Eng; 2006 Apr; 12(4):775-88. PubMed ID: 16674291
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional-construct bioreactor conditioning in human tendon tissue engineering.
Woon CY; Kraus A; Raghavan SS; Pridgen BC; Megerle K; Pham H; Chang J
Tissue Eng Part A; 2011 Oct; 17(19-20):2561-72. PubMed ID: 21612572
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering of flexor tendons: the effect of a tissue bioreactor on adipoderived stem cell-seeded and fibroblast-seeded tendon constructs.
Angelidis IK; Thorfinn J; Connolly ID; Lindsey D; Pham HM; Chang J
J Hand Surg Am; 2010 Sep; 35(9):1466-72. PubMed ID: 20807624
[TBL] [Abstract][Full Text] [Related]
20. Effects of a peracetic acid disinfection protocol on the biocompatibility and biomechanical properties of human patellar tendon allografts.
Lomas RJ; Jennings LM; Fisher J; Kearney JN
Cell Tissue Bank; 2004; 5(3):149-60. PubMed ID: 15509904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
